(Q51050227)

27 March 2018

title

Psychiatric and cognitive profile in Anderson-Fabry patients: a preliminary study. (English)

1 reference

27 March 2018

4

Gheona Altarescu

1 reference

27 March 2018

author name string

Perri Segal

1

1 reference

27 March 2018

Yoav Kohn

2

1 reference

27 March 2018

Yehuda Pollak

3

1 reference

27 March 2018

Esti Galili-Weisstub

5

1 reference

27 March 2018

Annick Raas-Rothschild

6

1 reference

27 March 2018

publication date

15 June 2010

1 reference

27 March 2018

Journal of Inherited Metabolic Disease

published in

1 reference

27 March 2018

volume

33

1 reference

27 March 2018

issue

4

1 reference

27 March 2018

page(s)

429-436

1 reference

27 March 2018

A diagnostic interview: the schedule for affective disorders and schizophrenia

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9133-3

Quantification of brain tissue alterations in Fabry disease using diffusion-tensor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9133-3

Psychiatric disorders in patients with Fabry's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9133-3

Psychosis in Fabry Disease and Treatment With Phenoxybenzamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10545-010-9133-3

The NUCOG: validity and reliability of a brief cognitive screening tool in neuropsychiatric patients.

21 January 2018

1 reference

12 December 2020

White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions

1 reference

12 December 2020

Psychosis in a patient with Fabry's disease and treatment with aripiprazole

1 reference

12 December 2020

The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis

1 reference

12 December 2020

White matter damage on diffusion tensor imaging correlates with age-related cognitive decline.

1 reference

12 December 2020

White matter hyperintensities and subclinical infarction: associations with psychomotor speed and cognitive flexibility

1 reference

12 December 2020

Automated and visual scoring methods of cerebral white matter hyperintensities: relation with age and cognitive function

1 reference

12 December 2020

Decreased nitric oxide bioavailability in a mouse model of Fabry disease

1 reference

12 December 2020

Standardized assessment of cognitive functioning during development and aging using an automated touchscreen battery

1 reference

12 December 2020

Psychological complications of patients with Gaucher disease

1 reference

12 December 2020

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

12 December 2020

Lysosomal storage disorders: emerging therapeutic options require early diagnosis

1 reference

12 December 2020

1 reference

12 December 2020

Regional cerebral hyperperfusion and nitric oxide pathway dysregulation in Fabry disease: reversal by enzyme replacement therapy

1 reference

12 December 2020

The vascular dementia of Fabry's disease

1 reference

12 December 2020

White matter hyperintensities in late life depression: a systematic review

1 reference

12 December 2020

Depression in adults with Fabry disease: a common and under-diagnosed problem.

1 reference

12 December 2020

Psychiatric findings in four female carriers of Fabry disease.

1 reference

12 December 2020

CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 98 hemizygous males

1 reference

12 December 2020

Neurological presentation of Fabry's disease in a 52 year old man.

1 reference

12 December 2020

Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females

1 reference

12 December 2020

Neuropsychological executive functions and DSM-IV ADHD subtypes

1 reference

12 December 2020

[Psychiatric and neuropsychological signs and symptoms in patients with fabry disease: literature review]

1 reference

12 December 2020

Standardization and norms for a Hebrew naming test

1 reference

12 December 2020

White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study.

1 reference

12 December 2020

The cerebral vasculopathy of Fabry disease.

1 reference

12 December 2020

Screening for depression in chronic obstructive pulmonary disease

1 reference

12 December 2020

Psychological aspects of patients with Fabry disease

1 reference

12 December 2020

Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey

1 reference

12 December 2020

Enzyme replacement therapy for Fabry disease: proving the clinical benefit

1 reference

12 December 2020

White matter lesion severity in male and female patients with Fabry disease

1 reference

12 December 2020

Depression and cardiovascular disease: role of nitric oxide

1 reference

12 December 2020

White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.

1 reference

12 December 2020

Neurology of Fabry disease.

1 reference

12 December 2020

Females with Fabry disease frequently have major organ involvement: lessons from the Fabry Registry.

1 reference

12 December 2020

Preliminary validity of "integneuro": a new computerized battery of neurocognitive tests.

1 reference

12 December 2020

Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population

1 reference

12 December 2020

Voxel based analyses of diffusion tensor imaging in Fabry disease.

1 reference

12 December 2020

10.1007/S10545-010-9133-3

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018